Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 1836-1838, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gazzolo, D.
Right arrow Articles by Michetti, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gazzolo, D.
Right arrow Articles by Michetti, F.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2001;47:1836-1838.)
© 2001 American Association for Clinical Chemistry, Inc.


Technical Briefs

Increased Urinary S100B Protein as an Early Indicator of Intraventricular Hemorrhage in Preterm Infants: Correlation with the Grade of Hemorrhage

Diego Gazzolo1, Matteo Bruschettini1, Mario Lituania2, Giovanni Serra1, Wanda Bonacci1 and Fabrizio Michetti3a

Departments of
1 Pediatrics and
2 Obstetrics and Gynecology, Giannina Gaslini Children’s University Hospital, I-16147 Genoa, Italy
3 Institute of Anatomy, Catholic University, Largo Francesco Vito, 1 I-00168 Rome, Italy

aauthor for correspondence: fax 39-630154813, e-mail fabrizio.michetti@rm.unicatt.it

Intraventricular hemorrhage (IVH) is the most common form of cerebral hemorrhage in preterm infants, affecting ~15–20% (1). Despite accurate postnatal monitoring, IVH is difficult to diagnose during the first 72 h after birth because at this stage, clinical symptoms and radiologic assessment of brain damage may still be silent (2). The availability in these patients of quantitative indicators suggesting subclinical lesions at a time when the monitoring indicators are unable to detect bleeding is therefore important. Furthermore, quantification of the extent of the hemorrhaged lesion could permit the prevention and/or treatment of clinical neurologic damage.

S100B is an acidic calcium-binding protein found in the nervous system, where it is concentrated in glial cells (3). The presence of increased S100B in the blood and cerebrospinal fluid (CSF) is a consolidated marker of brain damage in adults and children (4)(5)(6)(7)(8) and has been proposed recently for use in preterm newborns developing IVH (9). We have detected the S100B protein in the urine of preterm newborns under normal conditions and established reference values for the protein at the first urination (10). The present work, extending from the earlier study, investigates urine S100B in preterm newborns developing IVH to offer an indicator for the early detection of IVH.

We performed a case-control study on 18 preterm newborns (29–35 weeks of gestation) with IVH in whom urine S100B was measured at first urination (time 0) and at 24 (time 1), 48 (time 2), and 72 h of age (time 3). IVH was diagnosed at 72 h after birth by ultrasound scanning (11): eight infants were classified as grade II (IVH without ventricular dilatation); eight as grade III (IVH with ventricular dilatation); and two . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
Emerg. Med. J.Home page
A Pickering, J Carter, I Hanning, and W Townend
Emergency department measurement of urinary S100B in children following head injury: can extracranial injury confound findings?
Emerg. Med. J., February 1, 2008; 25(2): 88 - 89.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Gazzolo, E. Marinoni, R. Di Iorio, M. Lituania, M. Marras, M. Bruschettini, P. Bruschettini, R. Frulio, F. Michetti, F. Petraglia, et al.
High Maternal Blood S100B Concentrations in Pregnancies Complicated by Intrauterine Growth Restriction and Intraventricular Hemorrhage
Clin. Chem., May 1, 2006; 52(5): 819 - 826.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
D. Gazzolo, E. Marinoni, R. Di Iorio, M. Bruschettini, M. Kornacka, M. Lituania, U. Majewska, G. Serra, and F. Michetti
Measurement of Urinary S100B Protein Concentrations for the Early Identification of Brain Damage in Asphyxiated Full-term Infants
Arch Pediatr Adolesc Med, December 1, 2003; 157(12): 1163 - 1168.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. Michetti and D. Gazzolo
S100B Protein in Biological Fluids: A Tool for Perinatal Medicine
Clin. Chem., December 1, 2002; 48(12): 2097 - 2104.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Gazzolo, M. Bruschettini, R. Di Iorio, E. Marinoni, M. Lituania, M. Marras, R. Sarli, P. L. Bruschettini, and F. Michetti
Maternal Nitric Oxide Supplementation Decreases Cord Blood S100B in Intrauterine Growth-retarded Fetuses
Clin. Chem., April 1, 2002; 48(4): 647 - 650.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.